Anti-Tumor CAS 127-07-1 Hydroxyurea API Hydroxyurea Powder Hydroxyurea

• Varieties: General Disease Prevention Medicine
• Component: Hydroxyurea
• Type: The First Class
• Pharmacodynamic Influential Factors: Animal Species
• Storage Method: Normal
• Product Name: Hydroxyurea
• Model NO.: D-sung Hydroxyurea
• Name: Hydroxyurea Powder
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 127-07-1
• Mf: CH4n2o2
• Storage Tempera: 0-6c
• Melting Point: 142-146
• Density: 1.457
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 5000kg/Month

Product Description

Anti-Tumor CAS 127-07-1 Hydroxyurea API Hydroxyurea Powder Hydroxyurea

Product Description

Product Details

 

Product name	Hydroxyurea
Appearance	White Powder
MF	CH4N2O2
Assay	99%

It inhibits nucleotide reductase and prevents the conversion of cytidylic acid to deoxycytidylic acid, thereby inhibiting DNA synthesis. It acts selectively on S-phase cells. It is rapidly absorbed orally, with peak blood concentrations in 1 hour and disappears in 6 hours. It crosses the erythrocyte membrane and the blood-brain barrier. It is excreted mainly by the kidneys.

 

 

(1) it is used as an anticancer drug. (2) it is used to produce other chemicals. For example, it can react with 2-methyl-3-oxo-butyric acid ethyl ester to get 1-hydroxy-5,6-dimethyl-1H-pyrimidine-2,4-dione. This reaction needs reagent NaOEt and solvent ethanol at ambient temperature.
For the treatment of chronic myelogenous leukemia, but also for the treatment of metastatic ovarian cancer, primary head and neck squamous cell carcinoma, intractable psoriasis. Recently, the U.S. Food and Drug Administration (FDA) is approved for the treatment of sickle cell disease and as cheap cure AIDS virus (HIV) effective drugs.

 

Specification